| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.01 |